Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie has announced a new clinical study titled ‘A ...

Exercise in general can help patients manage symptoms, but without head-to-head trials, the ‘best’ exercise is the one the patient can do well and will stick with, experts say.

Researchers are developing a greater understanding of Parkinson’s disease, the fastest growing neurodegenerative disease ...

Ophidion, Inc., a biotechnology company pioneering non-invasive delivery of gene-silencing and large-molecule therapeutics to the brain, and Neuronasal, Inc., a clinical-stage company advancing ...

Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have come a long way over the past few decades focusing on managing symptoms and ...

More than 1 million Americans live with tremors, slowed movement and speech changes caused by Parkinson's disease—a ...

Parkinson's disease (PD) is an age-related, progressive, neurodegenerative condition, caused by loss of dopamine-producing neurons.

In a recent study published in The Journal of Neuroscience, researchers at the University of Alabama at Birmingham took a different approach to dyskinesia and treated it like a “bad motor memory.” ...

Austin, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Parkinson’s Disease Treatment Market Size & Growth Outlook According to SNS Insider, the global Parkinson’s Disease Treatment Market was valued at $5.37 ...

People with restless leg syndrome may also have a higher risk for Parkinson's disease, a study from the Republic of Korea has ...

Sakra World Hospital has announced the launch of its Parkinson’s Disease Clinic, a dedicated, multidisciplinary centre ...